Bladder Cancer Academy 2017 - Cancer Therapy Advisor

Why LUGPA Embraces Managing Advanced Genitourinary Cancers

Chapter 1

Neal Shore, MD, FACS

Chapter 2

Bladder Cancer Biomarkers: New and Old

Bladder Cancer Biomarkers: New and Old

Michael Cookson, MD, and Herbert Lepor, MD

Chapter 3

AUA Guidelines: Non-muscle Invasive Bladder Cancer

AUA Guidelines: Non-muscle Invasive Bladder Cancer

Sam Chang, MD, and Herbert Lepor, MD

Chapter 4

Intravesical Therapy: When Bacillus Calmette-Guerin Fails

Intravesical Therapy: When Bacillus Calmette-Guerin Fails

Noah Hahn, MD

Chapter 5

Bladder-sparing Strategies

Bladder-sparing Strategies

Trinity Bivalacqua, MD, PhD

Chapter 6

Immunotherapy for Advanced Bladder Cancer: The Next Frontier

Immunotherapy for Advanced Bladder Cancer: The Next Frontier

Arjun Balar, MD

Chapter 7

Targeted Therapies for Renal Cell Carcinoma

Targeted Therapies for Renal Cell Carcinoma

Won Kim, MD

Chapter 8

Immunotherapy of Renal Cell Carcinoma

Immunotherapy of Renal Cell Carcinoma

Hans Hammers, MD, PhD

Chapter 9

Genitourinary Oncology: A Peek Over the Horizon

Genitourinary Oncology: A Peek Over the Horizon

Dan Theodorescu, MD, PhD

Next hm-playlist in Bladder Cancer

Bladder Cancer Advisor – Plimack